Interacting Drugs |
Rifampin and isoniazid vs Dabigatran Etexilate |
Security Level |
 |
Mechanism |
Dabigatran Etexilate: P-glycoprotein/ABCB1 Inducers may decrease the serum concentration of Dabigatran Etexilate. |
Management |
Avoid concurrent use of dabigatran with a p-glycoprotein inducer when possible. Closely monitor for decreased levels/effects of dabigatran if concomitantly administering a p-glycoprotein inducer, particularly strong inducers. |
Rifampin and isoniazid vs Dabigatran Etexilate
Post Review about Rifampin and isoniazid vs Dabigatran Etexilate Click here to cancel reply.
Other Interactions of Rifampin and isoniazid
Other Interactions of Dabigatran Etexilate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.